How I treat: the selection and acquisition of unrelated cord blood grafts
- 24 February 2011
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 117 (8), 2332-2339
- https://doi.org/10.1182/blood-2010-04-280966
Abstract
Use of unrelated donor cord blood (CB) as an alternative stem cell source is increasing, and yet there is little information to guide transplant centers in the unique aspects of the search and selection of CB grafts. There is no mechanism to easily access the global inventory of CB units, nor is the product information provided by all banks standardized. To address these challenges, this manuscript reviews the logistics of the search, selection process, and acquisition of CB grafts as practiced by our center. Topics include who should be considered for a CB search, how to access the global CB inventory, and how to balance total nucleated cell dose and human leukocyte antigen match in unit selection. We discuss aspects of unit quality and other graft characteristics (processing methods, unit age, availability of attached segments, infectious disease, and hemoglobinopathy screening) to be considered. We incorporate these considerations into a unit selection algorithm, including how to select double-unit grafts. We also describe how we plan for unit shipment and the role of backup grafts. This review aims to provide a framework for CB unit selection and help transplantation centers perform efficient CB searches.This publication has 37 references indexed in Scilit:
- Availability of Cord Blood Extends Allogeneic Hematopoietic Stem Cell Transplant Access to Racial and Ethnic MinoritiesTransplantation and Cellular Therapy, 2010
- Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisThe Lancet Oncology, 2010
- A “No-wash” Albumin-Dextran Dilution Strategy for Cord Blood Unit Thaw: High Rate of Engraftment and a Low Incidence of Serious Infusion ReactionsTransplantation and Cellular Therapy, 2009
- Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignanciesProceedings of the National Academy of Sciences of the United States of America, 2009
- Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 unitsBlood, 2009
- Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell doseBlood, 2009
- Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation centerBlood, 2009
- Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensityBlood, 2009
- Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA MatchTransplantation and Cellular Therapy, 2008
- Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic diseaseBlood, 2007